- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01657084
Stopping and Preventing Epileptic Seizures Using a Partial Rebreathing Mask (EpiCapno)
May 19, 2016 updated by: University of Aarhus
By enabling a partial rebreathing of expired gas, a moderate respiratory acidosis is induced, without causing hypoxia in the patient.
Based on the scientific literature on the subject, the study hypothesis is that the fall in body pH will be able to stop and/or prevent epileptic brain activity.
Study Overview
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aarhus, Denmark, 8000
- Aarhus University Hospital
-
Dianalund, Denmark
- The Epilepsy Hospital Filadelfia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 76 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Epilepsy
- 18-80 years
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Tonic-clonic seizures
Patients with tonic-clonis seizures are observed in a video/EEG room.
In the case of seizures, the treatment mask or dummy mask are administered, according to a randomized cross-over study design.
|
The CDA (Carbon Dioxide Accumulation) mask effectuates an increase in the inspired CO2 fraction, while allowing an adequate supply of fresh air to the patient.
The dummy mask is similar in appearance to the treatment mask, but causes only a negligible change in blood gases
|
|
Experimental: Generalized Paroxysms
Patients with generalized epileptic paroxysms are observed by EEG during baseline, treatment mask and dummy mask use, according to a randomized cross-over study design.
|
The CDA (Carbon Dioxide Accumulation) mask effectuates an increase in the inspired CO2 fraction, while allowing an adequate supply of fresh air to the patient.
The dummy mask is similar in appearance to the treatment mask, but causes only a negligible change in blood gases
|
|
Experimental: Group 3
Patients with epileptic paroxysms are observed by EEG during baseline, treatment mask and dummy mask use, according to a randomized cross-over study design.
|
The CDA (Carbon Dioxide Accumulation) mask effectuates an increase in the inspired CO2 fraction, while allowing an adequate supply of fresh air to the patient.
The dummy mask is similar in appearance to the treatment mask, but causes only a negligible change in blood gases
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of epileptic seizure (subgroup 1)
Time Frame: Duration of mask treatment during acute seizures: approx. 3 minutes from start of mask treatment until end of seizure
|
Length of epileptic seizure with treatment mask vs. dummy mask
|
Duration of mask treatment during acute seizures: approx. 3 minutes from start of mask treatment until end of seizure
|
|
Frequency of epileptic paroxysms (subgroups 2 and 3)
Time Frame: Duration of mask treatment: 45 minutes (group 2) or 10 minutes (group 3) during which patient is monitored with EEG
|
Frequency of epileptic paroxysms as measured by EEG, treatment mask vs. dummy mask
|
Duration of mask treatment: 45 minutes (group 2) or 10 minutes (group 3) during which patient is monitored with EEG
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oxygen saturation during mask treatment
Time Frame: Duration of mask treatment
|
Measures oxygen saturation using a pulse oximeter during mask treatment
|
Duration of mask treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jakob Christensen, M.D., Ph.d., Aarhus University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2012
Primary Completion (Actual)
September 1, 2015
Study Completion (Actual)
November 1, 2015
Study Registration Dates
First Submitted
August 1, 2012
First Submitted That Met QC Criteria
August 1, 2012
First Posted (Estimate)
August 3, 2012
Study Record Updates
Last Update Posted (Estimate)
May 20, 2016
Last Update Submitted That Met QC Criteria
May 19, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012051485
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epilepsy
-
NaviFUS CorporationTaipei Veterans General Hospital, TaiwanCompletedDrug Resistant Epilepsy | Epilepsy, Drug Resistant | Intractable Epilepsy | Refractory Epilepsy | Drug Refractory Epilepsy | Epilepsy, Drug Refractory | Epilepsy, Intractable | Medication Resistant EpilepsyTaiwan
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
University of British ColumbiaTerminatedJuvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence EpilepsyCanada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Oslo University HospitalCompletedEpilepsy | Generalized Epilepsy | Focal EpilepsyNorway
-
UCB Pharma SACompletedEpilepsy, Tonic-clonicPoland, Sweden, Hungary, Czechia
-
UCB PharmaCompletedEpilepsy, Tonic-clonic
-
Institute of Child HealthGreat Ormond Street Hospital for Children NHS Foundation TrustNot yet recruitingEpilepsy Intractable | Epilepsy in Children
-
University Hospital, LilleCompletedFocal Epilepsy | Epilepsy IntractableFrance
-
Xuanwu Hospital, BeijingPeking University; Beijing Tiantan Hospital; Qilu Hospital of Shandong University and other collaboratorsRecruitingEpilepsy, Drug ResistantChina
Clinical Trials on CDA Mask
-
University of AarhusRehalerCompletedHyperventilation | Dysfunctional Breathing | Chronic Idiopathic Hyperventilation | Respiratory AlkalosisDenmark
-
ResMedCompletedObstructive Sleep ApneaUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingCOPD Exacerbation | Acute Respiratory Failure | Hypercapnia | Hypoventilation Obesity SyndromeFrance
-
Riphah International UniversityCompletedHealthy VolunteersPakistan
-
Philips Clinical & Medical Affairs GlobalTerminated
-
Johnson & Johnson Consumer Inc. (J&JCI)Completed
-
Fisher and Paykel HealthcareNot yet recruitingObesity Hypoventilation Syndrome (OHS) | COPD (Chronic Obstructive Pulmonary Disease)New Zealand
-
University of AlbertaCompletedRespiration; Insufficient or Poor, NewbornCanada